• A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab
• A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome
• A unique case of paraneoplastic lymphomatoid Papuloerythroderma of Ofuji with atypical clinical features
• Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study
• Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides
• Assessing T-cell receptor clonality by next-generation sequencing in atypical cutaneous lymphoid infiltrates and cutaneous T-cell lymphoma: A scoping review
• Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC Study
• Atypical Cutaneous Manifestation of Mycosis Fungoides: A Case Report
• Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and <em>SOCS1</em> mutation
• Breaking the Vicious Cycle of Staphylococcal aureus Skin Colonization and Progression of Cutaneous T-Cell Lymphoma
• Bullous mycosis fungoides-clinical indicator for an aggressive course of disease
• Cantharidin overcomes IL-2Ralpha signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species
• CASE OF THE TRANSFORMATION OF PSORIASIS INTO CUTANEOUS T-CELL LYMPHOMA
• Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas
• Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019
• Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders
• Coexistence of large cell transformed mycosis fungoides and diffuse large B-cell lymphoma in one patient
• Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab
• Concomitant cutaneous T-cell lymphoma and biclonal B-cell lymphoproliferative disorder
• Concurrent papular and dyshidrotic mycosis fungoides: A case report in a patient with skin of color
• Cutaneous Anaplastic T-Cell Lymphoma Mimicking a Small Abscess: A Case Report
• Cutaneous Involvement by Refractory Celiac Disease Type 2 Histologically Mimicking Mycosis Fungoides
• Cutaneous Lymphoma in a Tertiary Skin Hospital and Referral Centre in Nepal
• Cutaneous peri-ocular involvement in angioimmunoblastic T-cell lymphoma
• Cutaneous T cell Lymphoma in Skin of Color: A Review
• Cutaneous T-cell Lymphoma
• Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System
• Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic
• Cutaneous T-cell lymphoma following dupilumab use - A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)
• Cutavirus Infection in Large-Plaque Parapsoriasis, a Premalignant Condition of Mycosis Fungoides
• Delays in Diagnosis in Cutaneous T Cell Lymphoma: A Retrospective Study on Clinical Course and Time to Death
• Delays in diagnosis in cutaneous T-cell lymphoma: A retrospective study on clinical course and time to death
• Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System
• Dermatoscopy and Histology of Primary Cutaneous Aggressive Epidermotropic CD8+ T-Cell Lymphoma
• Dermoscopic features of primary cutaneous extranodal natural killer (NK)/T-cell lymphoma
• Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL)
• Diagnosis and Treatment of Skin Lesions in Renal Transplant Recipients: A Retrospective Review
• Drug eruption and cutaneous metastasis in a patient with ALK-negative anaplastic large T-cell lymphoma after tislelizumab
• DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype
• EBV + B cell-derived exosomes promote EBV-associated T/NK-cell lymphoproliferative disease immune evasion by STAT3/IL-10/PD-L1 pathway
• Editorial: Overcoming challenges in microbial immunology: 2022
• Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early-stage mycosis fungoides and the association with plaque lesions
• Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cu
• Efficacy of verdinexor for the treatment of naive canine epitheliotropic cutaneous T-cell lymphoma: An open-label pilot study
• Erfolgreiche Behandlung einer lymphomatoiden Papulose mit Chlormethin‐Gel
• Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study
• Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
• H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma
• High-frequency ultrasonography: one of the modern imaging diagnostic methods in dermatology. Authors' own experience and review
• Histopathologic and Clinical Characterization of Brentuximab Vedotin-associated Rash
• Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
• Improving disease-specific survival for patients with Sezary syndrome in the modern era of systemic therapies
• Intraoral CD30+ T-Cell Lymphoproliferative Disorder with Lymphomatoid Papulosis Type C Features Mimics Lymphoma Histopathologically and Immunohistochemically
• LAIR1 prevents excess inflammatory tissue damage in S. aureus skin infection and Cutaneous T-cell Lymphoma
• Leukomelanoderma Resembling Hyperpigmented Mycosis Fungoides
• Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group
• Metabolomics analyses reveal the crucial role of ERK in regulating metabolic pathways associated with the proliferation of human cutaneous T-cell lymphoma cells treated with Glabridin
• Mogamulizumab-associated rash - Case series and review of the literature
• Mogamulizumab‐assoziierter Rash – Fallserie und aktuelle Literatur
• Morphoea presenting histopathologically as mycosis fungoides: an illustrative series of four cases
• Mycosis Fungoides Palmaris et Plantaris Mimicking "Dyshidrotic Eczema": A Case Report
• Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months
• On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome
• Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder
• Palliating hematologic oncologic emergencies with radiation in the age of targeted systemic therapies: three illustrative cases
• Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma
• Plasma cell and neutrophil enriched neovascularization with granulomatous lymphangitis in POEMS syndrome
• Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte Leukemia
• Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification
• Primary cutaneous EBV+ extranodal NK/T-cell lymphoma of gamma/delta T-cell lineage in the posttransplantation setting
• Primary cutaneous extranodal natural killer/T-cell lymphoma (nasal-type) presenting as bilateral necrotic plaques on the feet
• Primary cutaneous lymphoproliferations in the gray zone between marginal zone lymphoma and CD4(+) small/medium T-cell lymphoproliferative disease
• Progression of CD8-positive Sézary syndrome from mycosis fungoides following dupilumab treatment
• Radiation therapy for the management of T cell cutaneous lymphomas. Updated results of the role of low dose total skin electron beam (TSEB) therapy
• Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
• Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
• Reply to: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"
• Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study."
• Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study."
• Response to Hasan et al's "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"
• Response to Hasan et al's "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"
• Response to Shih et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study."
• Response to Shih et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"
• Reverse causation bias: A simulation study comparing first- and second-line treatments with an overlap of symptoms between treatment indication and studied outcome
• Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan
• Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
• Sézary Syndrome in West Sweden: Exploring Epidemiology, Clinical Features, and Treatment Patterns in a Registry-Based Retrospective Analysis
• Single nucleotide polymorphism profiles of canine T-cell and null-cell lymphomas
• Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature
• Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes
• The association of atopic dermatitis and cutaneous T-cell lymphoma: A multicentre cohort study
• The efficacy of long-term psoralen plus ultraviolet A and low-dose interferon-a combination therapy in mycosis fungoides: A literature review
• The fifth edition of the WHO-Classification - what is new for cutaneous lymphomas?
• Time-dependent change of T cell receptor clonality: From large plaque parapsoriasis to early mycosis fungoides
• Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells
• Toxic epidermal necrolysis-like cutaneous toxicity following chimeric antigen receptor T-cell therapy in recurrent large B-cell lymphoma
• Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry
• Unmet needs in treating itch: reaching beyond eczema
• Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sezary syndrome with low blood burden
• Whole-Transcriptome Sequencing-Based Profiling of the Cutaneous Virome in Patients with Secondary Immunodeficiency